New York: 03:32 || London: 08:32 || Mumbai: 12:02 || Singapore: 14:32

News & Analysis » Asia

Avacta Group Signs Distribution Agreement For Optim With Cold Spring Biotech

February 3, 2011, Thursday, 05:23 GMT | 00:23 EST | 09:53 IST | 12:23 SGT

(RTTNews) - Avacta Group PLC (AVCT.L) said it signed a distribution agreement for Optim with Cold Spring Biotech Corp. in Mainland China, Hong Kong and Taiwan.

The company stated that Optim has been developed to accelerate and reduce the cost of drug development by providing early analysis of compounds to identify the best candidates and to define the optimal processing conditions.

Further, Avacta Group noted that the quantum leap in efficiency and reduction in cost of analysis allows drug developers to gain a greater insight into candidate drug compounds at a much earlier stage of development.